Methodological issues in pharmacokinetic-pharmacodynamic modelling

被引:41
|
作者
Bellissant, E
Sébille, V
Paintaud, G
机构
[1] Fac Med, Lab Pharmacol Expt & Clin, F-35043 Rennes, France
[2] Hop Brettoneau, Lab Pharmacol & Toxicol, Tours, France
关键词
D O I
10.2165/00003088-199835020-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article presents the theoretical and practical aspects involved in the design and analysis of pharmacokinetic-pharmacodynamic modelling studies. The main features of the protocol of pharmacokinetic-pharmacodynamic studies are discussed with special focus on experimental designs in relation to individual and population approaches. Some basic pharmacodynamic models (such as linear, log-linear, hyperbolic and sigmoid models) are presented as well as more complex time-dependent models (effect compartment and physiological indirect response, tolerance models) which are required when the concentration-effect relationship shows a hysteresis loop. The methods of estimation, with special focus on the individual and populations approaches, are covered, along with the way pharmacodynamic models and methods of estimation can be applied to real data and the information required to criticise the results of modelling. We also present some real problems frequently encountered when performing pharmacokinetic-pharmacodynamic modelling and give some potential solutions (problems with hysteresis loops, lack of convergence, problems with residuals). The last section discusses the significance of pharmacodynamic parameters.
引用
收藏
页码:151 / 166
页数:16
相关论文
共 50 条
  • [41] The pharmacokinetic-pharmacodynamic modelling framework as a tool to predict drug resistance evolution
    Witzany, Christopher
    Rolff, Jens
    Regoes, Roland R.
    Igler, Claudia
    MICROBIOLOGY-SGM, 2023, 169 (07):
  • [42] Pharmacokinetic-Pharmacodynamic Modelling of Opioids in Healthy Human Volunteers. A MiniReview
    Lorenzini, Kuntheavy Ing
    Daali, Youssef
    Dayer, Pierre
    Desmeules, Jules
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 110 (03) : 219 - 226
  • [43] Population pharmacokinetic-pharmacodynamic modelling of angiotensin receptor blockade in healthy volunteers
    Csajka, C
    Buclin, T
    Fattinger, K
    Brunner, HR
    Biollaz, J
    CLINICAL PHARMACOKINETICS, 2002, 41 (02) : 137 - 152
  • [44] Assessment of the Potential for Displacement Interactions with Sugammadex A Pharmacokinetic-Pharmacodynamic Modelling Approach
    Zwiers, Alex
    van den Heuvel, Michiel
    Smeets, Jean
    Rutherford, Samantha
    CLINICAL DRUG INVESTIGATION, 2011, 31 (02) : 101 - 111
  • [45] Integrated pharmacokinetic-pharmacodynamic modelling to evaluate antimicrobial prophylaxis in abdominal surgery
    Zelenitsky, S. A.
    Lawson, C.
    Calic, D.
    Ariano, R. E.
    Roberts, J. A.
    Lipman, J.
    Zhanel, G. G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (10) : 2902 - 2908
  • [46] Population Pharmacokinetic-Pharmacodynamic Modelling of Angiotensin Receptor Blockade in Healthy Volunteers
    Chantal Csajka
    Thierry Buclin
    Karin Fattinger
    Hans R. Brunner
    Jérôme Biollaz
    Clinical Pharmacokinetics, 2002, 41 : 137 - 152
  • [47] Pharmacokinetic-pharmacodynamic modelling of recombinant human erythropoietin in athletes - A population approach
    Gaudard, A
    Varlet-Marie, E
    Audran, M
    Gomeni, R
    Bressolle, F
    CLINICAL DRUG INVESTIGATION, 2003, 23 (03) : 167 - 179
  • [48] Utilisation of Pharmacokinetic-Pharmacodynamic Modelling and Simulation in Regulatory Decision-Making
    Jogarao V. S. Gobburu
    Patrick J. Marroum
    Clinical Pharmacokinetics, 2001, 40 : 883 - 892
  • [49] Pharmacokinetic-pharmacodynamic modelling of the antipyretic effect of two oral formulations of ibuprofen
    Trocóniz, IF
    Armenteros, S
    Planelles, MV
    Benítez, J
    Calvo, R
    Domínguez, R
    CLINICAL PHARMACOKINETICS, 2000, 38 (06) : 505 - 518
  • [50] Pharmacokinetic-pharmacodynamic modelling of zopiclone effects on human central nervous system
    Luurila, H
    Olkkola, KT
    PHARMACOLOGY & TOXICOLOGY, 1996, 78 (05): : 348 - 353